Literature DB >> 16937504

Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection.

Mohammad Javad Kaviani1, Behzad Behbahani, Mohammad Jafar Mosallaii, Fatemeh Sari-Aslani, Seyed Alireza Taghavi.   

Abstract

AIM: To assess the possible role of occult HBV infection in the pathogenesis of chronic hepatitis in Iranian patients.
METHODS: After exclusion of autoimmune, metabolic and viral etiologies, 104 consecutive adult patients with histologic and biochemical features of chronic hepatitis and negative HBsAg were enrolled in the study. Qualitative PCR with a sensitivity of 150 x 10(3) copies/L, using two primers for Pre-S and core regions was applied to measure presence of HBV DNA in serum of the patients.
RESULTS: All 104 patients completed the study. Qualitative HBV DNA was positive in two patients (1.9%).
CONCLUSION: Occult HBV infection has negligible role in the pathogenesis of cryptogenic chronic hepatitis in Iranian patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937504      PMCID: PMC4087411          DOI: 10.3748/wjg.v12.i31.5048

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Hepatitis B virus infection in patients with idiopathic liver disease.

Authors:  T J Liang; Y Baruch; E Ben-Porath; R Enat; L Bassan; N V Brown; N Rimon; H E Blum; J R Wands
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

Review 2.  Hepatitis B and transplantation.

Authors:  C L Davis; D R Gretch; R L Carithers
Journal:  Infect Dis Clin North Am       Date:  1995-12       Impact factor: 5.982

3.  Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection.

Authors:  Y Y Zhang; E Nordenfelt; B G Hansson
Journal:  Scand J Infect Dis       Date:  1996

4.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

Authors:  M G Ghany; B Ayola; F G Villamil; R G Gish; S Rojter; J M Vierling; A S Lok
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

5.  Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.

Authors:  P Paterlini; G Gerken; E Nakajima; S Terre; A D'Errico; W Grigioni; B Nalpas; D Franco; J Wands; M Kew
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

6.  Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients.

Authors:  R G Gish; J Y Lau; L Brooks; J W Fang; S L Steady; J C Imperial; R Garcia-Kennedy; C O Esquivel; E B Keeffe
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

7.  Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

Authors:  T I Huo; J C Wu; P C Lee; G Y Chau; W Y Lui; S H Tsay; L T Ting; F Y Chang; S D Lee
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

8.  Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.

Authors:  H T Chung; C L Lai; A S Lok
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

9.  "Occult" hepatitis B virus as source of infection in liver transplant recipients.

Authors:  O Chazouillères; D Mamish; M Kim; K Carey; L Ferrell; J P Roberts; N L Ascher; T L Wright
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

10.  A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.

Authors:  J Kato; K Hasegawa; N Torii; K Yamauchi; N Hayashi
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  6 in total

Review 1.  Cryptogenic chronic hepatitis and its changing guise in adults.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

Review 2.  Clinical significance of occult hepatitis B virus infection.

Authors:  Miriam Romero; Antonio Madejón; Conrado Fernández-Rodríguez; Javier García-Samaniego
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

3.  Occult hepatitis B among Iranian hepatitis C patients.

Authors:  Ahmad Shavakhi; Babak Norinayer; Fateme Sadat Esteghamat; Mohamad Seghatoleslami; Mahsa Khodadustan; Mohamad Hosein Somi; Mohsen Masoodi; Mohamad Reza Zali
Journal:  J Res Med Sci       Date:  2009-01       Impact factor: 1.852

4.  Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of iran.

Authors:  Seyed Jalal Hashemi; Eskandar Hajiani; Abdolrahim Masjedizadeh; Manoochehr Makvandi; Ali Akbar Shayesteh; Seyed Pejman Alavinejad; Ahmad Kadkhodaei; Heshmatollah Shahbazian; Farzad Jasemi; Mohamad Karimi
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

Review 5.  Update on occult hepatitis B virus infection.

Authors:  Manoochehr Makvandi
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

6.  Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, Addis Ababa Ethiopia.

Authors:  Selam Bogale Gissa; Mengistu Erkie Minaye; Biruk Yeshitela; Gizachew Gemechu; Abebech Tesfaye; Dawit Hailu Alemayehu; Abel Shewaye; Amir Sultan; Adane Mihret; Andargachew Mulu
Journal:  Sci Rep       Date:  2022-08-01       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.